Prostate cancer is one of the most commonly diagnosed cancers in men worldwide. With increasing life expectancy and improved screening awareness, more men are being diagnosed at earlier and more treatable stages. When detected early, prostate cancer is highly manageable and often curable. Even in advanced stages, modern therapies allow long-term disease control with good quality of life.
Dr. Lovedeep Singh Chauhan, Consultant Surgical Oncologist at Max Super Speciality Hospital, Mohali, provides evidence-based, personalized prostate cancer treatment using modern surgical and multidisciplinary approaches. With expertise in minimally invasive and robotic oncologic surgery, Dr. Chauhan focuses on achieving optimal cancer control while preserving urinary and sexual function whenever possible.
The prostate is a small, walnut-shaped gland located below the urinary bladder and in front of the rectum. It surrounds the urethra — the tube that carries urine from the bladder out of the body. The prostate plays a role in producing seminal fluid, which nourishes and transports sperm.
Because of its location, any enlargement or tumor in the prostate can affect urinary flow and sexual function.
Prostate cancer develops when cells within the prostate begin to grow uncontrollably. Most prostate cancers are adenocarcinomas, meaning they arise from the glandular cells that produce prostate fluid.
In many men, prostate cancer grows slowly and may remain confined to the gland for years. However, some forms are aggressive and can spread to lymph nodes, bones, or other organs if not treated appropriately.
Understanding whether a tumor is low-risk, intermediate-risk, or high-risk is critical in planning the right treatment.
Several factors can increase the likelihood of developing prostate cancer:
Risk increases significantly after the age of 50. It is uncommon in younger men.
Men with a father or brother diagnosed with prostate cancer have higher risk. Genetic mutations such as BRCA1 and BRCA2 may also contribute.
High-fat diets, obesity, and sedentary lifestyles are associated with increased risk.
Testosterone plays a role in prostate cell growth, which is why hormonal therapy is effective in advanced disease.
Although these factors increase risk, prostate cancer can develop even in men without obvious risk factors. Screening and awareness are essential.
Prostate cancer may remain silent early on, but awareness of warning signs is crucial.
Any persistent urinary or unexplained bone symptoms should prompt medical evaluation.
Early detection is key to effective management and better outcomes.
PSA is a blood test that measures a protein produced by the prostate. Elevated levels may indicate cancer but can also rise due to benign enlargement or infection.
A physical examination allows the physician to detect hard or irregular areas in the prostate. Men above 50, or above 45 with risk factors, should discuss screening with a specialist.
Accurate diagnosis and staging guide effective treatment planning.
MRI identifies suspicious areas and guides targeted biopsies, improving detection accuracy. Biopsy confirms diagnosis using TRUS-guided or MRI-fusion targeted techniques. Gleason Score and Grade Group are determined from pathology.
High-risk cases may require PSMA PET-CT, CT scan, or bone scan to evaluate spread of cancer and guide treatment planning.
Staging determines the extent of disease spread and guides treatment planning. PSA level and Gleason score are also used to classify patients into risk categories.
Risk stratification based on stage, PSA levels, and Gleason score helps determine the most appropriate treatment approach.
Treatment is individualized based on cancer stage, grade, patient age, overall health, and personal preferences.
For low-risk, slow-growing cancers, immediate treatment may not be necessary. Careful monitoring with regular PSA tests, imaging, and periodic biopsies is advised. This approach avoids unnecessary side effects while ensuring timely intervention if the cancer progresses.
Complete removal of the prostate gland, seminal vesicles, and sometimes pelvic lymph nodes. Types include:
Minimally invasive and robotic approaches provide smaller incisions, reduced blood loss, less postoperative pain, faster recovery, and shorter hospital stay. Nerve-sparing techniques preserve erectile function when oncologically safe.
Expertise: Dr. Lovedeep Singh Chauhan specializes in advanced minimally invasive cancer surgery, ensuring oncologic precision while prioritizing functional outcomes.
Radiation may be used as primary treatment for localized cancer, adjuvant therapy after surgery, or combined with hormonal therapy in high-risk cases. Modern techniques allow precise targeting with reduced side effects.
Lowers testosterone to slow cancer growth. Used in locally advanced disease, metastatic cancer, or combined with radiation therapy to improve outcomes.
In metastatic or hormone-resistant prostate cancer, systemic treatments such as chemotherapy, targeted therapy, or immunotherapy may be recommended. Multidisciplinary tumor board planning ensures optimal, evidence-based care.
Treatments may cause urinary incontinence or bowel disturbances. Modern techniques and pelvic floor physiotherapy significantly aid recovery.
Erectile dysfunction can occur, but nerve-sparing surgery and structured erectile rehabilitation programs help restore function over time.
Fatigue is common after treatment. Proper rehabilitation, exercise, and nutrition support overall functional recovery and quality of life.
Prostate cancer management requires more than a surgical procedure. It demands accurate staging, proper risk stratification, multidisciplinary coordination, and long-term follow-up. Dr. Lovedeep Singh Chauhan, Consultant Surgical Oncologist at Max Super Speciality Hospital, Mohali, provides comprehensive uro-oncology care with a strong focus on:
With training from premier cancer institutes and experience in complex oncologic procedures, Dr. Chauhan ensures high standards of safety and precision. Patients benefit from advanced infrastructure including modern imaging, dedicated cancer operating theatres, ICU backup, and coordinated oncology services.
Early consultation improves treatment outcomes and helps avoid unnecessary delays.